Ditchcarbon
  • Contact
  1. Organizations
  2. Avidity, LLC
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 3 months ago

Avidity, LLC Sustainability Profile

Company website

Avidity, LLC, headquartered in the United States, is a pioneering force in the biotechnology industry, specialising in the development of innovative therapeutics. Founded in 2012, the company has made significant strides in advancing its proprietary Avidity Technology™, which uniquely harnesses the power of antibody-drug conjugates to target and treat various diseases, including cancer and genetic disorders. With a strong operational presence across North America and Europe, Avidity has established itself as a leader in the biopharmaceutical sector. The company’s commitment to research and development has led to notable achievements, including successful clinical trials and partnerships with major pharmaceutical firms. Avidity’s core offerings stand out for their precision and efficacy, positioning the company as a key player in the evolving landscape of targeted therapies.

DitchCarbon Score

How does Avidity, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Avidity, LLC's score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.

27%

Let us know if this data was useful to you

Avidity, LLC's reported carbon emissions

Avidity, LLC, headquartered in the US, currently does not report any carbon emissions data, as there are no available figures for kg CO2e. Additionally, the company has not established specific reduction targets or commitments under initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges. As a result, Avidity, LLC's climate commitments remain unspecified, and there is no inherited emissions data from a parent or related organisation. The absence of reported emissions and reduction initiatives highlights a potential area for future development in their sustainability strategy.

How Carbon Intensive is Avidity, LLC's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Avidity, LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Avidity, LLC's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Avidity, LLC is in US, which has a low grid carbon intensity relative to other regions.

Avidity, LLC's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Avidity, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Avidity, LLC's Emissions with Industry Peers

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Fulcrum Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

BioMarin

US
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

PYC Therapeutics Limited

AU
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Sarepta Therapeutics

US
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Shire plc

IE
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251120.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy